Belladonna Tincture and Rosiglitazone Maleate

• Generic Name: belladonna
• Dosage Forms: n.a.
• Other Brand Names: Belladonna Tincture, Belladonna Leaf

Belladonna Tincture is a plant also known as Atropa Belladonna Tincture, Atropa acuminata, Baccifère, Belle-Dame, Belle-Galante, Bouton Noir, Cerise du Diable, Deadly Nightshade, Devil's Cherries, Devil's Herb, Divale, Dwale, Dwayberry, Grande Morelle, Guigne de la Côte, Herbe à la Mort, Herbe du Diable, Morelle Furieuse, Naughty Man's Cherries, Poison Black Cherries, Suchi, and other names.

Belladonna Tincture has been used in alternative medicine as an aid in treating arthritis pain, colds or hay fever, bronchospasms caused by asthma or whooping cough, hemorrhoids, nerve problems, Parkinson's disease, colic, irritable bowel syndrome, and motion sickness.

It is not certain whether Belladonna Tincture is effective in treating any medical condition, and Belladonna Tincture can be toxic. Medicinal use of this product has not been approved by the FDA. Belladonna Tincture should not be used in place of medication prescribed for you by your doctor.

Belladonna Tincture is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.

Belladonna Tincture may also be used for purposes not listed in this product guide.

• Generic Name: rosiglitazone
• Dosage Forms: n.a.
• Other Brand Names: Avandia

Used as monotherapy or in combination with a sulfonylurea, metformin, or a sulfonylurea and metformin as an adjunct to diet and exercise for the management of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM).

May be added to glyburide/metformin fixed-combination therapy if hyperglycemia is not adequately controlled with the fixed combination.

May be used in combination with repaglinide if hyperglycemia is not adequately controlled with repaglinide monotherapy.

May use fixed combination of rosiglitazone/metformin (Avandamet) when treatment with rosiglitazone and metformin is appropriate.

May use fixed combination of rosiglitazone/glimepiride (Avandaryl) when treatment with rosiglitazone and glimepiride is appropriate.

Metformin is the preferred initial oral antidiabetic agent for patients with type 2 diabetes mellitus. Thiazolidinediones are one of several second-line agents used with other oral antidiabetic agents (e.g., metformin) in patients who are inadequately controlled on their current oral therapy. Because of potential for serious adverse effects, American Diabetes Association (ADA) recommends that clinicians carefully weigh the potential risks and benefits of thiazolidinediones versus other second-line agents (i.e., insulin, sulfonylureas).

Use in combination with insulin not recommended.

Because endogenous insulin is required for activity, not indicated for type 1 diabetes mellitus or diabetic ketoacidosis.